Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
Operating Income
Quest Diagnostics Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Chemed Corp
NYSE:CHE
|
Operating Income
$373.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$15.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Quest Diagnostics Inc's Operating Income?
Operating Income
1.3B
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Operating Income amounts to 1.3B USD.
What is Quest Diagnostics Inc's Operating Income growth rate?
Operating Income CAGR 10Y
2%
Over the last year, the Operating Income growth was -3%. The average annual Operating Income growth rates for Quest Diagnostics Inc have been -20% over the past three years , 1% over the past five years , and 2% over the past ten years .